Andrew C. Lam
Corporate Officer/Principal en Armetheon, Inc. .
Origen de la red de primer grado Andrew C. Lam.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Armetheon, Inc.
Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Andrew C. Lam a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Washington University in St. Louis | College/University | Corporate Officer/Principal | |
TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
Optivia Biotechnology, Inc.
Optivia Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Optivia Biotechnology, Inc. provides contract research organization offering drug transporter research services and solutions to biotechnology, pharmaceutical and academic organizations. It offers regulatory DDI studies, transporter screening, tranporter profiling, and custom development services. The firm's products include TransFlex Single Transporter Assay Plates,TransFlex Multi-Transporter Model Plates, and Certified Efflux Transporter Vesicles. The company was founded by Yong Huang, Pascal Druzgala and Peter G. Milner in 2007 and is headquartered in Santa Clara, CA. | Pharmaceuticals: Major | Founder Founder | |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree | |
Xenon Vision, Inc.
Xenon Vision, Inc. Miscellaneous Commercial ServicesCommercial Services Part of W World Corp., Xenon Vision, Inc. is a vision research concern. The company is based in Alachua, FL. Xenon Vision was acquired by Pharmatec, Inc. on November 03, 1992. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder | |
Mount St. Joseph University | College/University | Undergraduate Degree | |
University of Florida | College/University | Doctorate Degree | |
Université de Montpellier | College/University | Doctorate Degree | |
ABV LLC
ABV LLC Investment ManagersFinance ABV LLC(Ascent Biomedical) is a venture capital firm founded in 2004 by Steven I Hochberg, Geoffrey W Smith and Steve Hochberg. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
The Athenaeum of Ohio | College/University | Graduate Degree | |
Lifeline Technologies, Inc.
Lifeline Technologies, Inc. BiotechnologyHealth Technology Lifeline Technologies, Inc. operates as a health sciences development company which focuses on novel strategies. It offers ChoLESStolife, a non-prescription and non-synthetic cholesterol absorption inhibitor for the reduction of human cholesterol using a fat-free delivery system for soy sterols and stanols. The company was registered by Curtis A. Spilburg and Richard E. Ostlund on October 1, 2002 and is headquartered in Hendersonville, NC. | Biotechnology | Director/Board Member | |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Pharmaceuticals: Major | Director/Board Member | |
Advanced Therapies, Inc. | Founder | ||
Retrotope, Inc.
Retrotope, Inc. Pharmaceuticals: MajorHealth Technology Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Director/Board Member | |
SinuSys Corp.
SinuSys Corp. Medical SpecialtiesHealth Technology SinuSys Corp. develops medical device therapies to improve the sinus health of patients with chronic sinusitis. Its products include Vent-OS sinus dilation system, Restora steroid-eluting spacer, and SinuSys product pipeline. The company was founded by Jerome Hester and Thomas A. Schreck in 2010 and is headquartered in Palo Alto, CA. | Medical Specialties | Director/Board Member | |
AshHill Investments LLC
AshHill Investments LLC Investment ManagersFinance AshHill Investments LLC (AshHill Investments) is a venture capital firm founded in 2011. The firm is headquartered in Ft. Thomas, Kentucky. | Investment Managers | Chief Executive Officer | |
Uc College of Law | College/University | Graduate Degree | |
Renexxion LLC
Renexxion LLC Pharmaceuticals: MajorHealth Technology Renexxion LLC is a gastrointestinal biopharmaceutical company. It develops naronapride. The company was founded by Peter G. Milner, Muralitharan Kengatharan , and Pascal J. Druzgala in 2014 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Founder Founder | |
Steven Roland Smith LLC | Corporate Officer/Principal |
Estadísticas
Internacional
Estados Unidos | 20 |
Reino Unido | 3 |
Canadá | 2 |
Francia | 2 |
Irlanda | 2 |
Sectorial
Health Technology | 12 |
Consumer Services | 8 |
Commercial Services | 3 |
Finance | 3 |
Operativa
Director/Board Member | 15 |
Founder | 12 |
Corporate Officer/Principal | 7 |
Chief Tech/Sci/R&D Officer | 7 |
Chief Executive Officer | 4 |
Las relaciones más conectadas
Insiders | |
---|---|
Peter G. Milner | 18 |
Pascal J. Druzgala | 9 |
Elizabeth A. Ahrens | 5 |
Heather Lake | 1 |
- Bolsa de valores
- Insiders
- Andrew C. Lam
- Conexiones Empresas